Literature DB >> 16493200

The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population.

Neelum T Aggarwal1, Julia L Bienias, David A Bennett, Robert S Wilson, Martha Clare Morris, Julie A Schneider, Raj C Shah, Denis A Evans.   

Abstract

The relationship between smoking status and incident Alzheimer's disease (AD) was investigated in a random stratified sample of a biracial community in Chicago. Analyses are based on 1,064 persons (of 1,134 evaluated) who had data on smoking status, disease incidence, and key covariates such as apolipoprotein allele status. During a mean of about 4 years of follow-up, 170 persons met criteria for incident AD. Current smoking was associated with increased risk of incident AD (OR = 3.4, 95% CI = 1.4-8.0) compared to persons who never smoked. There was no apparent increase in risk of AD for former smokers compared to persons who never smoked (OR = 0.9, 95% CI = 0.5-1.7). Apolipoprotein E allele status modified this association in that former smokers with a upsilon4 allele were less likely to develop AD (p = 0.04) than those who never smoked. Former smokers also appeared to have a reduced risk of developing AD as their pack-years of smoking increased (p = 0.02)such that the odds of developing AD increased by 50% for every 10 years of smoking cessation (OR = 1.3, CI = 0.9-1.7). The results suggest that older people who currently smoke are more likely to develop AD compared to those who never smoked; the relation between those who used to smoke but quit and the risk of AD is complex and requires further research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493200     DOI: 10.1159/000091654

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  29 in total

1.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Type 2 diabetes and ethnic disparities in cognitive impairment.

Authors:  James M Noble; Jennifer J Manly; Nicole Schupf; Ming-Xing Tang; José A Luchsinger
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

Review 3.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Relationship between metabolic and vascular conditions and cognitive decline among older Mexican Americans.

Authors:  Brian Downer; Mukaila A Raji; Kyriakos S Markides
Journal:  Int J Geriatr Psychiatry       Date:  2015-05-29       Impact factor: 3.485

5.  EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE.

Authors:  Brian Giunta; Juan Deng; Jingji Jin; Edin Sadic; Saja Rum; Huadong Zhou; Paul Sanberg; Jun Tan
Journal:  Technol Innov       Date:  2012-01-01

Review 6.  Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-06       Impact factor: 21.566

7.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

8.  Effect of Apolipoprotein E epsilon4 on the association between health behaviors and cognitive function in late midlife.

Authors:  Séverine Sabia; Mika Kivimaki; Meena Kumari; Martin J Shipley; Archana Singh-Manoux
Journal:  Mol Neurodegener       Date:  2010-06-01       Impact factor: 14.195

Review 9.  Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.

Authors:  Christianna Purnell; Sujuan Gao; Christopher M Callahan; Hugh C Hendrie
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

Review 10.  Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature.

Authors:  James M Noble; Nikolaos Scarmeas; Panos N Papapanou
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.